1. Home
  2. CGEM vs GHLD Comparison

CGEM vs GHLD Comparison

Compare CGEM & GHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • GHLD
  • Stock Information
  • Founded
  • CGEM 2016
  • GHLD 1960
  • Country
  • CGEM United States
  • GHLD United States
  • Employees
  • CGEM N/A
  • GHLD N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • GHLD Finance: Consumer Services
  • Sector
  • CGEM Health Care
  • GHLD Finance
  • Exchange
  • CGEM Nasdaq
  • GHLD Nasdaq
  • Market Cap
  • CGEM 530.0M
  • GHLD 977.9M
  • IPO Year
  • CGEM 2021
  • GHLD 2020
  • Fundamental
  • Price
  • CGEM $7.68
  • GHLD $19.81
  • Analyst Decision
  • CGEM Strong Buy
  • GHLD Hold
  • Analyst Count
  • CGEM 6
  • GHLD 6
  • Target Price
  • CGEM $28.17
  • GHLD $17.90
  • AVG Volume (30 Days)
  • CGEM 350.6K
  • GHLD 147.0K
  • Earning Date
  • CGEM 08-07-2025
  • GHLD 08-07-2025
  • Dividend Yield
  • CGEM N/A
  • GHLD 2.52%
  • EPS Growth
  • CGEM N/A
  • GHLD 63.18
  • EPS
  • CGEM N/A
  • GHLD 0.71
  • Revenue
  • CGEM N/A
  • GHLD $1,131,796,000.00
  • Revenue This Year
  • CGEM N/A
  • GHLD $5.64
  • Revenue Next Year
  • CGEM N/A
  • GHLD $26.37
  • P/E Ratio
  • CGEM N/A
  • GHLD $27.84
  • Revenue Growth
  • CGEM N/A
  • GHLD 32.57
  • 52 Week Low
  • CGEM $6.85
  • GHLD $11.21
  • 52 Week High
  • CGEM $21.01
  • GHLD $20.15
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 45.96
  • GHLD 81.04
  • Support Level
  • CGEM $7.29
  • GHLD $19.79
  • Resistance Level
  • CGEM $7.94
  • GHLD $20.02
  • Average True Range (ATR)
  • CGEM 0.39
  • GHLD 0.07
  • MACD
  • CGEM -0.01
  • GHLD -0.14
  • Stochastic Oscillator
  • CGEM 61.01
  • GHLD 30.00

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

Share on Social Networks: